HSP90 inhibition induces premature senescence in small cell lung cancer cells, and HSP90 is identified as a potential therapeutic target for lung cancer 4, indicating that intervention of HSP90 may represent a promising strategy for treatment of cancer. This evidence concerns the gene HSP90AA1 and lung cancer.